Exhibit 99.1

LIFE TECHNOLOGIES CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS

	December 31,			December 31,
	2009		-	2008 (1)
(in thousands)	(unaudited)
ASSETS
Current assets:
Cash and short-term investments	$	648,074		$	448,317
Trade accounts receivable, net of allowance for doubtful accounts		591,058			580,907
Inventories		353,222			420,029
Deferred income taxes		19,822			25,563
Prepaid expenses and other current assets		183,988			137,355
Total current assets		1,796,164			1,612,171
Property and equipment, net		829,032			748,056
Goodwill		3,783,806			3,574,779
Intangible assets, net		2,071,607			2,291,767
Long-term investments		380,167			490,853
Other assets		254,964	-		181,133
Total assets	$	9,115,740	-	$	8,898,759
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	481,701		$	80,000
Accounts payable, accrued expenses and other current liabilities		840,597			821,813
Income taxes		63,425			105,429
Total current liabilities		1,385,723			1,007,242
Long-term debt		2,620,089			3,396,420
Pension liabilities		155,934			201,833
Income taxes		811,340			739,343
Other long-term liabilities		115,986			97,383
Stockholders’ equity		4,026,668	-		3,456,538
Total liabilities and stockholders’ equity	$	9,115,740	-	$	8,898,759

⁽¹⁾ December 31, 2008 Consolidated Balance Sheet includes the impacts of the retrospective application of the bifurcation requirement prescribed by the ASC Topic of Debt with Conversion and Other Options and the reclassification of amounts to conform with equity method presentation of the Company’s investment in the MDS/Sciex joint venture.